306 related articles for article (PubMed ID: 2985992)
21. Advances in the isolation of HTLV-III from patients with AIDS and AIDS-related complex and from donors at risk.
Markham PD; Salahuddin SZ; Popovic M; Patel A; Veren K; Fladager A; Orndorff S; Gallo RC
Cancer Res; 1985 Sep; 45(9 Suppl):4588s-4591s. PubMed ID: 2990690
[TBL] [Abstract][Full Text] [Related]
22. Epidemiological trends of AIDS in the United States.
Curran JW; Morgan WM; Starcher ET; Hardy AM; Jaffe HW
Cancer Res; 1985 Sep; 45(9 Suppl):4602s-4604s. PubMed ID: 2990692
[TBL] [Abstract][Full Text] [Related]
23. AIDS and haemophilia.
Carr R
Biomed Pharmacother; 1985; 39(7):347-50. PubMed ID: 3006817
[TBL] [Abstract][Full Text] [Related]
24. Assessment of screening as a preventive technology: the example of HTLV-III/LAV antibody testing.
Ory HW; Koplan JP; Allen JR
Isr J Med Sci; 1986; 22(7-8):524-8. PubMed ID: 3640749
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
26. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease.
Ward JW; Bush TJ; Perkins HA; Lieb LE; Allen JR; Goldfinger D; Samson SM; Pepkowitz SH; Fernando LP; Holland PV
N Engl J Med; 1989 Oct; 321(14):947-52. PubMed ID: 2779617
[TBL] [Abstract][Full Text] [Related]
27. Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China.
Zeng Y; Fan J; Zhang Q; Wang PC; Tang DJ; Zhon SC; Zheng XW; Liu DP
AIDS Res; 1986 Dec; 2 Suppl 1():S147-9. PubMed ID: 3103638
[TBL] [Abstract][Full Text] [Related]
28. The Walter Reed staging classification for HTLV-III/LAV infection.
Redfield RR; Wright DC; Tramont EC
N Engl J Med; 1986 Jan; 314(2):131-2. PubMed ID: 2934633
[TBL] [Abstract][Full Text] [Related]
29. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex.
Resnick L; diMarzo-Veronese F; Schüpbach J; Tourtellotte WW; Ho DD; Müller F; Shapshak P; Vogt M; Groopman JE; Markham PD
N Engl J Med; 1985 Dec; 313(24):1498-504. PubMed ID: 2999592
[TBL] [Abstract][Full Text] [Related]
30. Protection of neonates from transfusion-associated AIDS by the use of CMV-seronegative blood before availability of specific serologic tests for HTLV-III (HIV).
Brady MT; Ng A
Am J Perinatol; 1987 Oct; 4(4):305-7. PubMed ID: 2820434
[TBL] [Abstract][Full Text] [Related]
31. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody testing at alternate sites.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 May; 35(17):284-7. PubMed ID: 3010070
[TBL] [Abstract][Full Text] [Related]
32. Acquired immunodeficiency syndrome (AIDS) associated with transfusions.
Curran JW; Lawrence DN; Jaffe H; Kaplan JE; Zyla LD; Chamberland M; Weinstein R; Lui KJ; Schonberger LB; Spira TJ
N Engl J Med; 1984 Jan; 310(2):69-75. PubMed ID: 6606780
[TBL] [Abstract][Full Text] [Related]
33. Seroepidemiological evidence for HTLV-III infection as the primary etiologic factor for acquired immunodeficiency syndrome.
Sarngadharan MG; Schüpbach J; Bruch L; Devico A; Markham PD; Wong-Staal F; Gallo RC
Prog Clin Biol Res; 1985; 182():309-27. PubMed ID: 2994105
[No Abstract] [Full Text] [Related]
34. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO
Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
[TBL] [Abstract][Full Text] [Related]
35. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
[TBL] [Abstract][Full Text] [Related]
36. Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state.
Laurence J; Brun-Vezinet F; Schutzer SE; Rouzioux C; Klatzmann D; Barré-Sinoussi F; Chermann JC; Montagnier L
N Engl J Med; 1984 Nov; 311(20):1269-73. PubMed ID: 6092953
[TBL] [Abstract][Full Text] [Related]
37. Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III).
Hirsch MS; Wormser GP; Schooley RT; Ho DD; Felsenstein D; Hopkins CC; Joline C; Duncanson F; Sarngadharan MG; Saxinger C
N Engl J Med; 1985 Jan; 312(1):1-4. PubMed ID: 2981106
[TBL] [Abstract][Full Text] [Related]
38. Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery.
Cohen ND; Muñoz A; Reitz BA; Ness PK; Frazier OH; Yawn DH; Lee H; Blattner W; Donahue JG; Nelson KE
N Engl J Med; 1989 May; 320(18):1172-6. PubMed ID: 2710190
[TBL] [Abstract][Full Text] [Related]
39. Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody-negative.
Cumming PD; Wallace EL; Schorr JB; Dodd RY
N Engl J Med; 1989 Oct; 321(14):941-6. PubMed ID: 2779616
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire.
Mann JM; Quinn TC; Francis H; Nzilambi N; Bosenge N; Bila K; McCormick JB; Ruti K; Asila PK; Curran JW
JAMA; 1986 Aug; 256(6):721-4. PubMed ID: 3014178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
